Cours InDex Pharmaceuticals Holding AB (publ) Nasdaq Stockholm
Actions
SE0008966295
Produits pharmaceutiques
CA 2024 * | - | CA 2025 * | - | Capitalisation | 218 M 2,35 Md 197 M |
---|---|---|---|---|---|
Résultat net 2024 * | -259 M -2,79 Md -235 M | Résultat net 2025 * | -221 M -2,38 Md -200 M | VE / CA 2024 * | - |
Dette nette 2024 * | 86,32 M 931 M 78,2 M | Dette nette 2025 * | 306 M 3,3 Md 277 M | VE / CA 2025 * | - |
PER 2024 * |
-0,83
x | PER 2025 * |
-1
x | Employés | - |
Rendement 2024 * |
-
| Rendement 2025 * |
-
| Flottant | 62,47% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Jenny Sundqvist
CEO | Chief Executive Officer | 53 | 01/01/23 |
Johan Gileus
DFI | Director of Finance/CFO | 59 | 01/05/17 |
Charlotte Admyre
CTO | Chief Tech/Sci/R&D Officer | 45 | - |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Uli Alf Hacksell
BRD | Director/Board Member | 74 | 01/01/16 |
Director/Board Member | 68 | 01/01/11 | |
Chairman | 72 | 01/01/11 |
Varia. 1 janv. | Capi. | |
---|---|---|
+31,06% | 682 Md | |
+30,35% | 586 Md | |
-3,42% | 364 Md | |
+18,02% | 327 Md | |
+4,27% | 285 Md | |
+15,53% | 240 Md | |
+10,16% | 209 Md | |
-8,14% | 203 Md | |
+8,12% | 165 Md |